Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13G/A - Contineum Therapeutics, Inc. Class A Common Stock | StockGist | StockGist

Companies
CTNM
SCHEDULE 13G/A

Home Top Movers Companies Concepts

Home Filings CTNMSCHEDULE 13G/A

SCHEDULE 13G/A

Beneficial Ownership

Amendment

Contineum Therapeutics, Inc. Class A Common Stock

Filed Jan 29, 2026

Accepted Jan 28, 2026, 7:00 PM ET

CIK 0001855175

View on SEC.gov Company Profile

Beneficial Ownership Report

Passive Investment

% of Class

10.00%

Reporting Person

Contineum Therapeutics, Inc.

Person Type

HC

CUSIP: 21217B100

Amendment History

3 filings

SCHEDULE 13G
Original
Feb 17, 20260001193125-26-052863
SCHEDULE 13G/A
Amendment 1
Viewing
Jan 29, 20260000038777-26-000010
SCHEDULE 13G/A
Amendment 2
Latest
Feb 17, 20260001346824-26-000037

Key Facts

% of Class

10.00%

Recent Filings

Contineum Therapeutics, Inc. Class A Common Stock4 weeks ago

Contineum Therapeutics, Inc. Class A Common Stock4 weeks ago

Contineum Therapeutics, Inc. Class A Common Stock1 months ago

Contineum Therapeutics, Inc. Class A Common Stock1 months ago

Contineum Therapeutics, Inc. Class A Common Stock1 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice